Profiling Myelodysplastic Syndromes by Mass Cytometry Demonstrates Abnormal Progenitor Cell Phenotype and Differentiation
G. K. Behbehani, R. Finck, N. Samusik, K. J. Sridhar, W. J. Fantl, P. L. Greenberg, G. P. Nolan
This paper uses mass cytometry to analyze MDS patient samples, identifying abnormal surface markers and differentiation patterns not detectable with traditional methods.
bioRxiv · Apr 12, 2019Cancer Biology